Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples